PMID

Data

Article Title

Organization

Rickettsia prowazekii methionine aminopeptidase as a promising target for the development of antibacterial agents.

Northern Illinois University

Discovery of Inhibitors of

Northern Illinois University

Synthesis and antitumor activity of 1,3,4-oxadiazole possessing 1,4-benzodioxan moiety as a novel class of potent methionine aminopeptidase type II inhibitors.

Nanjing University

Pyridinylquinazolines selectively inhibit human methionine aminopeptidase-1 in cells.

Johns Hopkins University School Of Medicine

QSAR study of anthranilic acid sulfonamides as inhibitors of methionine aminopeptidase-2 using LS-SVM and GRNN based on principal components.

Kermanshah University Of Medical Sciences

Subtype-selectivity of metal-dependent methionine aminopeptidase inhibitors.

Universit£T Heidelberg

A selective account of effective paradigms and significant outcomes in the discovery of inspirational marine natural products.

University Of California Santa Cruz

Investigation of novel fumagillin analogues as angiogenesis inhibitors.

Gilead Sciences

Synthesis and antitumor activity of 1,2,4-triazoles having 1,4-benzodioxan fragment as a novel class of potent methionine aminopeptidase type II inhibitors.

Nanjing University

Recent developments in fragment-based drug discovery.

Astex Therapeutics

Fumarranol, a rearranged fumagillin analogue that inhibits angiogenesis in vivo.

The Johns Hopkins University School Of Medicine

Design and synthesis of beta-amino-alpha-hydroxy amide derivatives as inhibitors of MetAP2 and HUVEC growth.

Celera

3-Amino-2-hydroxyamides and related compounds as inhibitors of methionine aminopeptidase-2.

Abbott Laboratories

Peptidyl hydroxamic acids as methionine aminopeptidase inhibitors.

The Ohio State University

Fumagalone, a reversible inhibitor of type 2 methionine aminopeptidase and angiogenesis.

Johns Hopkins University School Of Medicine

The Bengamides: A Mini-Review of Natural Sources, Analogues, Biological Properties, Biosynthetic Origins, and Future Prospects.

Colorado Mesa University

S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: I. Cellular, electrophysiological, and neurochemical profile in comparison with ropinirole.

Institut De Recherches Servier

S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.

Institut De Recherches Servier

Multicopy suppressors for novel antibacterial compounds reveal targets and drug efflux susceptibility.

Mcmaster University

1,2,3,4-Tetrahydroisoquinolinyl sulfamic acids as phosphatase PTP1B inhibitors.

Procter & Gamble Pharmaceuticals

Synthesis of potent C(2)-symmetric, diol-based hiv-1 protease inhibitors. Investigation of thioalkyl and thioaryl P1/P1' substituents.

Stockholm University